{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:39:29Z","timestamp":1787495969044,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(82300209)"],"award-info":[{"award-number":["(82300209)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(82300209)"],"award-info":[{"award-number":["(82300209)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(82300209)"],"award-info":[{"award-number":["(82300209)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(82300209)"],"award-info":[{"award-number":["(82300209)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(82300209)"],"award-info":[{"award-number":["(82300209)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(82300209)"],"award-info":[{"award-number":["(82300209)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17845-x","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T11:16:18Z","timestamp":1756725378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Construction of a prognostic risk model for acute myeloid leukemia based on exosomal genes and analysis of immune microenvironment characteristics"],"prefix":"10.1038","volume":"15","author":[{"given":"Min-xiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-sheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-qin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-qin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"17845_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000536152","volume":"147","author":"F Wachter","year":"2024","unstructured":"Wachter, F. & Pikman, Y. Pathophysiology of acute myeloid leukemia. Acta Haematol. 147, 229\u2013246. https:\/\/doi.org\/10.1159\/000536152 (2024).","journal-title":"Acta Haematol."},{"key":"17845_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-017-0416-0","volume":"10","author":"H Hackl","year":"2017","unstructured":"Hackl, H., Astanina, K. & Wieser, R. Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia. J. Hematol. Oncol. 10, 51. https:\/\/doi.org\/10.1186\/s13045-017-0416-0 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"17845_CR3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","volume":"10","author":"S Venugopal","year":"2024","unstructured":"Venugopal, S. & Sekeres, M. A. Contemporary management of acute myeloid leukemia: a review. JAMA Oncol. 10, 1417\u20131425. https:\/\/doi.org\/10.1001\/jamaoncol.2024.2662 (2024).","journal-title":"JAMA Oncol."},{"key":"17845_CR4","doi-asserted-by":"publisher","first-page":"e572","DOI":"10.1097\/hs9.0000000000000572","volume":"5","author":"F Thol","year":"2021","unstructured":"Thol, F. & Heuser, M. Treatment for relapsed\/refractory acute myeloid leukemia. HemaSphere 5, e572. https:\/\/doi.org\/10.1097\/hs9.0000000000000572 (2021).","journal-title":"HemaSphere"},{"key":"17845_CR5","doi-asserted-by":"publisher","first-page":"103175","DOI":"10.1155\/2014\/103175","volume":"2014","author":"E Conway O\u2019Brien","year":"2014","unstructured":"Conway O\u2019Brien, E., Prideaux, S. & Chevassut, T. The epigenetic landscape of acute myeloid leukemia. Adv. Hematol. 2014, 103175. https:\/\/doi.org\/10.1155\/2014\/103175 (2014).","journal-title":"Adv. Hematol."},{"key":"17845_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41408-021-00495-3","volume":"11","author":"N Daver","year":"2021","unstructured":"Daver, N., Venugopal, S. & Ravandi, F. FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm. Blood Cancer J. 11, 104. https:\/\/doi.org\/10.1038\/s41408-021-00495-3 (2021).","journal-title":"Blood Cancer J."},{"key":"17845_CR7","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nm.3364","volume":"19","author":"DS Krause","year":"2013","unstructured":"Krause, D. S. et al. Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat. Med. 19, 1513\u20131517. https:\/\/doi.org\/10.1038\/nm.3364 (2013).","journal-title":"Nat. Med."},{"key":"17845_CR8","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","volume":"164","author":"M Tkach","year":"2016","unstructured":"Tkach, M. & Th\u00e9ry, C. Communication by extracellular vesicles: where we are and where we need to go. Cell 164, 1226\u20131232. https:\/\/doi.org\/10.1016\/j.cell.2016.01.043 (2016).","journal-title":"Cell"},{"key":"17845_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tcb.2016.11.003","volume":"27","author":"SLN Maas","year":"2017","unstructured":"Maas, S. L. N., Breakefield, X. O. & Weaver, A. M. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell. Biol. 27, 172\u2013188. https:\/\/doi.org\/10.1016\/j.tcb.2016.11.003 (2017).","journal-title":"Trends Cell. Biol."},{"key":"17845_CR10","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/j.1600-0854.2011.01225.x","volume":"12","author":"A Bobrie","year":"2011","unstructured":"Bobrie, A., Colombo, M., Raposo, G. & Th\u00e9ry, C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 12, 1659\u20131668. https:\/\/doi.org\/10.1111\/j.1600-0854.2011.01225.x (2011).","journal-title":"Traffic"},{"key":"17845_CR11","doi-asserted-by":"publisher","first-page":"177541","DOI":"10.1016\/j.ejphar.2025.177541","volume":"996","author":"Y Qi","year":"2025","unstructured":"Qi, Y. et al. Discovery of Cmpd D6 (FH-001) as a efficiency enhancement and myelosuppression degradation small-molecule fms-like tyrosine kinase 3 inhibitor for the treatment of FLT3-ITD positive acute myeloid leukemia. Eur. J. Pharmacol. 996, 177541. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177541 (2025).","journal-title":"Eur. J. Pharmacol."},{"key":"17845_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12288-024-01765-3","volume":"40","author":"V Amiri","year":"2024","unstructured":"Amiri, V., Mirzaeian, A. & Noroozi-Aghideh, A. Non-mutational changes of autophagy marker LC3A in patients with acute myeloid leukemia; effect of DNA methylation and expression level of LncRNA-GAS5 and miRNA-155-5p, a case control study. Indian J. Hematol. Blood Transfus. 40, 621\u2013628. https:\/\/doi.org\/10.1007\/s12288-024-01765-3 (2024).","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"17845_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1042\/bst20120265","volume":"41","author":"TL Whiteside","year":"2013","unstructured":"Whiteside, T. L. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem. Soc. Trans. 41, 245\u2013251. https:\/\/doi.org\/10.1042\/bst20120265 (2013).","journal-title":"Biochem. Soc. Trans."},{"key":"17845_CR14","doi-asserted-by":"publisher","first-page":"7023168","DOI":"10.1155\/2020\/7023168","volume":"2020","author":"Q Dong","year":"2020","unstructured":"Dong, Q. et al. Levels and clinical significance of regulatory B cells and T cells in acute myeloid leukemia. Biomed. Res. Int. 2020, 7023168. https:\/\/doi.org\/10.1155\/2020\/7023168 (2020).","journal-title":"Biomed. Res. Int."},{"key":"17845_CR15","doi-asserted-by":"publisher","first-page":"113134","DOI":"10.1016\/j.colsurfb.2023.113134","volume":"222","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Inside-out extracellular vesicles-like biomimetic magnetic nanoparticles for efficient screening P-glycoprotein inhibitors to overcome cancer multidrug resistance. Colloids Surf. B Biointerfaces. 222, 113134. https:\/\/doi.org\/10.1016\/j.colsurfb.2023.113134 (2023).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"17845_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/leu.2017.259","volume":"32","author":"B Kumar","year":"2018","unstructured":"Kumar, B. et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia 32, 575\u2013587. https:\/\/doi.org\/10.1038\/leu.2017.259 (2018).","journal-title":"Leukemia"},{"key":"17845_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mdr2.70001","volume":"1","author":"Y Fang","year":"2025","unstructured":"Fang, Y. et al. Systematic investigation of tumor microenvironment and antitumor immunity with IOBR. Med. Res. 1, 136\u2013140. https:\/\/doi.org\/10.1002\/mdr2.70001 (2025).","journal-title":"Med. Res."},{"key":"17845_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mdr2.70004","volume":"1","author":"H Zhou","year":"2025","unstructured":"Zhou, H. et al. Optimized dynamic network biomarker Deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med. Res. 1, 10\u201313. https:\/\/doi.org\/10.1002\/mdr2.70004 (2025).","journal-title":"Med. Res."},{"key":"17845_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae276","author":"W Li","year":"2024","unstructured":"Li, W. et al. iMLGAM: integrated machine learning and genetic algorithm\u2013driven multi-omics analysis. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbae276 (2024).","journal-title":"Brief. Bioinform"},{"key":"17845_CR20","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"17845_CR21","doi-asserted-by":"publisher","first-page":"e70052","DOI":"10.1111\/jcmm.70052","volume":"28","author":"S Ghosh","year":"2024","unstructured":"Ghosh, S. et al. The theragnostic advances of exosomes in managing leukaemia. J. Cell. Mol. Med. 28, e70052. https:\/\/doi.org\/10.1111\/jcmm.70052 (2024).","journal-title":"J. Cell. Mol. Med."},{"key":"17845_CR22","doi-asserted-by":"publisher","first-page":"11295","DOI":"10.1038\/srep11295","volume":"5","author":"NI Hornick","year":"2015","unstructured":"Hornick, N. I. et al. Serum exosome MicroRNA as a minimally-invasive early biomarker of AML. Sci. Rep. 5, 11295. https:\/\/doi.org\/10.1038\/srep11295 (2015).","journal-title":"Sci. Rep."},{"key":"17845_CR23","doi-asserted-by":"publisher","first-page":"1683347","DOI":"10.1080\/2162402x.2019.1683347","volume":"9","author":"ZJ Xu","year":"2020","unstructured":"Xu, Z. J. et al. The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia. Oncoimmunology 9, 1683347. https:\/\/doi.org\/10.1080\/2162402x.2019.1683347 (2020).","journal-title":"Oncoimmunology"},{"key":"17845_CR24","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1002\/cncr.30203","volume":"122","author":"TM Kadia","year":"2016","unstructured":"Kadia, T. M. et al. TP53 mutations in newly diagnosed acute myeloid leukemia: clinicomolecular characteristics, response to therapy, and outcomes. Cancer 122, 3484\u20133491. https:\/\/doi.org\/10.1002\/cncr.30203 (2016).","journal-title":"Cancer"},{"key":"17845_CR25","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/s41375-022-01696-w","volume":"36","author":"M Li","year":"2022","unstructured":"Li, M. et al. METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4. Leukemia 36, 2586\u20132595. https:\/\/doi.org\/10.1038\/s41375-022-01696-w (2022).","journal-title":"Leukemia"},{"key":"17845_CR26","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1158\/0008-5472.CAN-19-0515","volume":"79","author":"M Hosseini","year":"2019","unstructured":"Hosseini, M. et al. Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in human acute myeloid leukemia. Cancer Res. 79, 5191\u20135203. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0515 (2019).","journal-title":"Cancer Res."},{"key":"17845_CR27","doi-asserted-by":"publisher","first-page":"101354","DOI":"10.1016\/j.genrep.2021.101354","volume":"25","author":"MMIM Khalil","year":"2021","unstructured":"Khalil, M. M. I. M., Sohaib, A., Mansour, M. M. & Genena, E. S. R. The role of ZNF384, DNAH17, and NDST2 gene expression in non-Hodgkin\u2019s lymphoma patients. Gene Rep. 25, 101354. https:\/\/doi.org\/10.1016\/j.genrep.2021.101354 (2021).","journal-title":"Gene Rep."},{"key":"17845_CR28","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2147\/jhc.S476612","volume":"11","author":"W Wan","year":"2024","unstructured":"Wan, W. et al. Incomplete thermal ablation-induced FOXP4-mediated promotion of malignant progression in liver cancer via NDST2. J. Hepatocell Carcinoma. 11, 1945\u20131959. https:\/\/doi.org\/10.2147\/jhc.S476612 (2024).","journal-title":"J. Hepatocell Carcinoma"},{"key":"17845_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10142-024-01363-6","volume":"24","author":"N Wang","year":"2024","unstructured":"Wang, N. et al. RUNX3 exerts tumor-suppressive role through inhibiting EXOSC4 expression. Funct. Integr. Genomics. 24, 103. https:\/\/doi.org\/10.1007\/s10142-024-01363-6 (2024).","journal-title":"Funct. Integr. Genomics"},{"key":"17845_CR30","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3389\/fonc.2019.01567","volume":"9","author":"L Zhu","year":"2019","unstructured":"Zhu, L. et al. THBS1 is a novel serum prognostic factor of acute myeloid leukemia. Front. Oncol. 9, 1567. https:\/\/doi.org\/10.3389\/fonc.2019.01567 (2019).","journal-title":"Front. Oncol."},{"key":"17845_CR31","doi-asserted-by":"publisher","first-page":"9321630","DOI":"10.1155\/2020\/9321630","volume":"2020","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. Bioinformatics analysis identifies key genes and pathways in acute myeloid leukemia associated with DNMT3A mutation. Biomed. Res. Int. 2020, 9321630. https:\/\/doi.org\/10.1155\/2020\/9321630 (2020).","journal-title":"Biomed. Res. Int."},{"key":"17845_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.18632\/oncotarget.10613","volume":"8","author":"M Yu","year":"2017","unstructured":"Yu, M. et al. Prognostic impact of MYH9 expression on patients with acute myeloid leukemia. Oncotarget 8, 156\u2013163. https:\/\/doi.org\/10.18632\/oncotarget.10613 (2017).","journal-title":"Oncotarget"},{"key":"17845_CR33","doi-asserted-by":"publisher","first-page":"834681","DOI":"10.3389\/fonc.2022.834681","volume":"12","author":"H Lan","year":"2022","unstructured":"Lan, H., Gao, Y., Zhao, Z., Mei, Z. & Wang, F. Ferroptosis: redox imbalance and hematological tumorigenesis. Front. Oncol. 12, 834681. https:\/\/doi.org\/10.3389\/fonc.2022.834681 (2022).","journal-title":"Front. Oncol."},{"key":"17845_CR34","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1182\/blood-2021-153256","volume":"138","author":"NJ Buteyn","year":"2021","unstructured":"Buteyn, N. J. et al. EZH2-mediated MHC class II Silencing drives immune evasion in AML with t(16;21) (FUS-ERG). Blood 138, 374. https:\/\/doi.org\/10.1182\/blood-2021-153256 (2021).","journal-title":"Blood"},{"key":"17845_CR35","doi-asserted-by":"publisher","first-page":"7156","DOI":"10.3390\/ijms25137156","volume":"25","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Tsukamoto, Y., Hori, M. & Iha, H. Disulfidptosis: a novel prognostic criterion and potential treatment strategy for diffuse large B-cell lymphoma (DLBCL). Int. J. Mol. Sci. 25, 7156. https:\/\/doi.org\/10.3390\/ijms25137156 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"17845_CR36","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.7150\/ijms.19682","volume":"14","author":"M Chen","year":"2017","unstructured":"Chen, M. et al. Verteporfin inhibits cell proliferation and induces apoptosis in human leukemia NB4 cells without light activation. Int. J. Med. Sci. 14, 1031\u20131039. https:\/\/doi.org\/10.7150\/ijms.19682 (2017).","journal-title":"Int. J. Med. Sci."},{"key":"17845_CR37","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.celrep.2017.12.055","volume":"22","author":"Y Xiu","year":"2018","unstructured":"Xiu, Y. et al. Stabilization of NF-\u03baB-inducing kinase suppresses MLL-AF9-induced acute myeloid leukemia. Cell. Rep. 22, 350\u2013358. https:\/\/doi.org\/10.1016\/j.celrep.2017.12.055 (2018).","journal-title":"Cell. Rep."},{"key":"17845_CR38","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1038\/s41467-022-32473-z","volume":"13","author":"H Song","year":"2022","unstructured":"Song, H. et al. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. Nat. Commun. 13, 4878. https:\/\/doi.org\/10.1038\/s41467-022-32473-z (2022).","journal-title":"Nat. Commun."},{"key":"17845_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.freeradbiomed.2008.10.027","volume":"46","author":"T Maraldi","year":"2009","unstructured":"Maraldi, T. et al. Induction of apoptosis in a human leukemic cell line via reactive oxygen species modulation by antioxidants. Free Radic Biol. Med. 46, 244\u2013252. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.10.027 (2009).","journal-title":"Free Radic Biol. Med."},{"key":"17845_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejphar.2016.03.044","volume":"780","author":"CL Bi","year":"2016","unstructured":"Bi, C. L. et al. Selenium inhibits Staphylococcus aureus-induced inflammation by suppressing the activation of the NF-\u03baB and MAPK signalling pathways in RAW264.7 macrophages. Eur. J. Pharmacol. 780, 159\u2013165. https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.044 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"17845_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpsychires.2018.11.021","volume":"109","author":"F Martini","year":"2019","unstructured":"Martini, F. et al. A multifunctional compound Ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic alzheimer\u2019s disease. J. Psychiatr Res. 109, 107\u2013117. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.11.021 (2019).","journal-title":"J. Psychiatr Res."},{"key":"17845_CR42","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.3892\/mmr.2016.4787","volume":"13","author":"W Wei","year":"2016","unstructured":"Wei, W. et al. Targeting Peroxiredoxin I potentiates 1,25-dihydroxyvitamin D3-induced cell differentiation in leukemia cells. Mol. Med. Rep. 13, 2201\u20132207. https:\/\/doi.org\/10.3892\/mmr.2016.4787 (2016).","journal-title":"Mol. Med. Rep."},{"key":"17845_CR43","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.33549\/physiolres.933367","volume":"65","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. & Choi, J. S. Effect of ginsenoside Rh-2 via activation of caspase-3 and Bcl-2-insensitive pathway in ovarian cancer cells. Physiol. Res. 65, 1031\u20131037 (2016).","journal-title":"Physiol. Res."},{"key":"17845_CR44","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.fitote.2011.05.005","volume":"82","author":"YJ Choi","year":"2011","unstructured":"Choi, Y. J., Yoon, J. H., Cha, S. W. & Lee, S. G. Ginsenoside Rh1 inhibits the invasion and migration of THP-1 acute monocytic leukemia cells via inactivation of the MAPK signaling pathway. Fitoterapia 82, 911\u2013919. https:\/\/doi.org\/10.1016\/j.fitote.2011.05.005 (2011).","journal-title":"Fitoterapia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17845-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17845-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17845-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T02:15:24Z","timestamp":1757470524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17845-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17845-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is based entirely on publicly available datasets from the Gene Expression Omnibus (GEO) (accession: GSE71014) and multi-omics data from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) projects. All data were anonymized and aggregated prior to analysis, in strict compliance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data used in this study are publicly accessible and anonymized. No individual patient data or identifiable information were collected, ensuring full compliance with privacy regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"32140"}}